Clinical trial
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
NCT03605550 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
- Lead sponsor
- Nationwide Children's Hospital
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- August 1, 2018
- Completion date
- March 1, 2029
- Enrollment
- 64 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse intrinsic pontine glioma, high grade glioma